|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 7/30/15 vTv Therapeutics Inc. 8-A12B 1:14K Summit Fin’l Pri… LLC/FA |
Document/Exhibit Description Pages Size 1: 8-A12B Registration of a Class of Securities HTML 11K
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF
SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
VTV THERAPEUTICS INC.
(Exact name of registrant as specified in its charter)
| Delaware | 47-3916571 | |
| (State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) | |
|
4170 Mendenhall Oaks Pkwy High Point, NC (336) 841-0300 |
27265 | |
| (Address of principal executive offices) | (Zip Code) |
Securities to be registered pursuant to Section 12(b) of the Act:
| Title of each class to be registered |
Name of each exchange on which each class is to be registered | |
| Class A common stock, par value $0.01 per share | The NASDAQ Stock Market LLC |
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective
pursuant to General Instruction A.(c), check the following box. þ
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box. o
Securities Act registration statement file number to which this form relates (if applicable): 333-204951
Securities to be registered pursuant to Section 12(g) of the Act: None
INFORMATION REQUIRED IN REGISTRATION STATEMENT
Item 1. Description of Registrant’s Securities to be Registered.
The securities to be registered hereby are shares of Class A common stock, par value $0.01 per share, of vTv Therapeutics Inc. (the “Registrant”). The information required by this Item 1 is incorporated herein by reference to the information set forth under “Description of Capital Stock” in the Registrant’s Registration Statement on Form S-1 (File No. 333-204951) under the Securities Act of 1933, as filed with the Securities and Exchange Commission on June 15, 2015, and as amended on June 19, 2015, July 1, 2015, July 13, 2015, July 20, 2015, July 23, 2015 and July 24, 2015 (the “S-1 Registration Statement”). Such information also will appear in the Registrant’s prospectus that forms a part of the S-1 Registration Statement, and such prospectus is incorporated herein by reference.
Item 2. Exhibits.
Not applicable.
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities and Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.
Date: July 30, 2015
| VTV THERAPEUTICS INC. | |||
| By: | /s/ Rudy C. Howard | ||
| Name: | Rudy C. Howard | ||
| Title: | Chief Financial Officer | ||
| This ‘8-A12B’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 7/30/15 | |||
| 7/24/15 | S-1/A | |||
| 7/23/15 | S-1/A | |||
| 7/20/15 | FWP, S-1/A | |||
| 7/13/15 | S-1/A | |||
| 7/1/15 | ||||
| 6/19/15 | S-1/A | |||
| 6/15/15 | S-1 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/29/24 vTv Therapeutics Inc. 424B2 1:123K Donnelley … Solutions/FA 4/29/24 vTv Therapeutics Inc. 424B2 1:223K Donnelley … Solutions/FA 4/10/24 vTv Therapeutics Inc. S-3 5:756K Donnelley … Solutions/FA 2/28/24 vTv Therapeutics Inc. 424B5 1:322K Donnelley … Solutions/FA 6/25/21 vTv Therapeutics Inc. 424B5 1:376K ActiveDisclosure/FA 6/15/21 vTv Therapeutics Inc. 424B3 1:280K ActiveDisclosure/FA 6/03/21 vTv Therapeutics Inc. S-3 3:398K ActiveDisclosure/FA 4/21/21 vTv Therapeutics Inc. 424B5 1:209K ActiveDisclosure/FA 4/09/21 vTv Therapeutics Inc. S-3/A 2:493K ActiveDisclosure/FA 3/18/21 vTv Therapeutics Inc. S-3 3:272K ActiveDisclosure/FA 1/14/21 vTv Therapeutics Inc. 424B5 1:343K ActiveDisclosure/FA 12/09/20 vTv Therapeutics Inc. 424B3 1:255K ActiveDisclosure/FA 11/24/20 vTv Therapeutics Inc. S-1 3:514K ActiveDisclosure/FA 8/03/20 vTv Therapeutics Inc. S-8 8/03/20 4:105K ActiveDisclosure/FA |